Target intelligence / Profile preview

Iron(3+)-hydroxamate-binding protein FhuD (FhuD)

Target
FhuD
Molecular classification
Transporter, Periplasmic binding protein, Class III solute-binding protein (SBP), Component of ATP-binding cassette (ABC) transporter system
01

Overview

FhuD is a soluble periplasmic binding protein found in gram-negative (e.g., Escherichia coli) and some gram-positive bacteria, functioning as part of a high-affinity ABC transporter system for iron acquisition. It binds ferrichrome and other hydroxamate-type siderophores, capturing the Fe3+-siderophore complex in the periplasm and delivering it to the FhuCDB (in E. coli) or similar membrane transport systems for active translocation across the cytoplasmic membrane. The process is essential for bacterial survival in iron-limited environments, such as within animal hosts, and contributes to bacterial virulence. FhuD exhibits a class III solute-binding protein fold; its ligand binding and conformational changes facilitate unidirectional iron transport and integration with membrane-bound transporter components. Targeting FhuD and related siderophore receptors is a proposed strategy for antimicrobial development, including "Trojan horse" antibiotics using siderophore mimics for selective drug uptake in bacteria.

Other names
Ferrichrome transporter FhuDIron(3+)-hydroxamate-binding protein FhuDPeriplasmic binding protein FhuDfhuD protein, E. coli
02

Mechanism of action

Drugs mimicking siderophore structure are internalized via FhuD-dependent transport (e.g., albomycin) Inhibition or blockage of iron acquisition via FhuD can disrupt bacterial growth and pathogenicity

03

Biological functions

Bacterial iron uptake (especially ferrichrome and related hydroxamate siderophores)Siderophore transportIron ion homeostasis
04

Disease associations

Infection (facilitates iron acquisition in pathogenic bacteria, relevant to bacterial virulence and growth in host environments)Antibiotic resistance (potential role in resistance or drug uptake through siderophore analogs)
05

Safety considerations

Selectivity: Targeting FhuD must avoid off-target effects on host iron transport mechanisms.Resistance: Bacteria may express alternative iron uptake systems as compensation.Immunogenicity: Siderophore-binding proteins may be weakly immunogenic, limiting vaccine utility.
06

Interacting drugs

Albomycin (an antibiotic structurally related to ferrichrome; FhuD, along with FhuA and related components, mediates uptake)

1 more in the full profile.

07

Biomarkers

FhuD and related siderophore receptor expression can serve as biomarkers for iron acquisition activity or bacterial virulence in some pathogens

Beyond the preview

Go deeper on Iron(3+)-hydroxamate-binding protein FhuD (FhuD).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Iron(3+)-hydroxamate-binding protein FhuD (FhuD).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call